Skip to content

爱康临床研究

US · ICLR #1235 按市值排名 上市于 1970
170.18 -4.95 -2.83%
实时 - 追踪5344个代码 - 心跳于544秒前 · 2026-10-16 19:30

最新新闻

  • 评级变动
    Truist Financial Upgrades Icon PLC(ICLR.US) to Buy Rating, Announces Target Price $207
    \u5e02\u573a\u8d44\u8baf · 2026/6/30
  • 评级变动
    Truist Financial Maintains Icon PLC(ICLR.US) With Buy Rating, Maintains Target Price $207
    \u5e02\u573a\u8d44\u8baf · 2026/6/30
  • 评级变动
    J.P. Morgan Maintains Icon PLC(ICLR.US) With Hold Rating, Raises Target Price to $165
    \u5e02\u573a\u8d44\u8baf · 2026/8/5
  • 评级变动
    A Quick Look at Today's Ratings for Icon PLC(ICLR.US), With a Forecast Between $187 to $197
    \u5e02\u573a\u8d44\u8baf · 2026/6/26
  • 评级变动
    Truist Financial Maintains Icon PLC(ICLR.US) With Hold Rating
    \u5e02\u573a\u8d44\u8baf · 2026/6/24
  • BofA Securities Upgrades Icon PLC(ICLR.US) to Hold Rating
    \u5e02\u573a\u8d44\u8baf · 2026/10/9
  • RBC Capital Maintains Icon PLC(ICLR.US) With Buy Rating, Maintains Target Price $185
    \u5e02\u573a\u8d44\u8baf · 2026/10/7
  • UBS Initiates Icon PLC(ICLR.US) With Hold Rating, Announces Target Price $195
    \u5e02\u573a\u8d44\u8baf · 2026/9/30
  • 评级变动
    A Quick Look at Today's Ratings for Icon PLC(ICLR.US), With a Forecast Between $160 to $220
    \u5e02\u573a\u8d44\u8baf · 2026/7/31
  • UBS Maintains Icon PLC(ICLR.US) With Hold Rating, Maintains Target Price $195
    \u5e02\u573a\u8d44\u8baf · 2026/10/3
  • 评级变动
    Truist Financial Maintains Icon PLC(ICLR.US) With Buy Rating
    \u5e02\u573a\u8d44\u8baf · 2026/9/17
  • 评级变动
    BofA Securities Maintains Icon PLC(ICLR.US) With Sell Rating, Maintains Target Price $125
    \u5e02\u573a\u8d44\u8baf · 2026/6/24
  • 评级变动
    Mizuho Securities Maintains Icon PLC(ICLR.US) With Buy Rating, Raises Target Price to $190
    \u5e02\u573a\u8d44\u8baf · 2026/6/27
  • 评级变动
    William Blair Initiates Icon PLC(ICLR.US) With Buy Rating
    \u5e02\u573a\u8d44\u8baf · 2026/7/30
  • 评级变动
    Citi Maintains Icon PLC(ICLR.US) With Hold Rating, Raises Target Price to $175
    \u5e02\u573a\u8d44\u8baf · 2026/9/18
  • 评级变动
    Baird Maintains Icon PLC(ICLR.US) With Buy Rating, Raises Target Price to $194
    \u5e02\u573a\u8d44\u8baf · 2026/7/31
  • 评级变动
    A Quick Look at Today's Ratings for Icon PLC(ICLR.US), With a Forecast Between $160 to $197
    \u5e02\u573a\u8d44\u8baf · 2026/6/25
  • Barclays Maintains Icon PLC(ICLR.US) With Hold Rating, Maintains Target Price $175
    \u5e02\u573a\u8d44\u8baf · 2026/10/7
  • 评级变动
    TD Cowen Maintains Icon PLC(ICLR.US) With Buy Rating, Maintains Target Price $197
    \u5e02\u573a\u8d44\u8baf · 2026/8/3
  • 评级变动
    Barclays Maintains Icon PLC(ICLR.US) With Hold Rating, Raises Target Price to $160
    \u5e02\u573a\u8d44\u8baf · 2026/6/24
  • 评级变动
    RBC Capital Maintains Icon PLC(ICLR.US) With Buy Rating, Maintains Target Price $185
    \u5e02\u573a\u8d44\u8baf · 2026/7/31
  • 评级变动
    William Blair Maintains Icon PLC(ICLR.US) With Buy Rating
    \u5e02\u573a\u8d44\u8baf · 2026/6/2
  • Earnings Call Summary | Icon PLC(ICLR.US) Q1 2026 Earnings Conference
    \u5e02\u573a\u8d44\u8baf · 2026/8/31

新闻标题为自动聚合内容,未经我们团队独立核实或编辑。

报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

爱康临床研究 讨论区 0 条评论

发表评论